In addition, although our test data shows that the serum SPRR2A level of GC patients is significantly lower than that before surgery, the change in serum SPRR2A concentration may be useful for dynamically monitoring the prognosis of GC patients undergoing surgical intervention. This evidence concerns the gene SPRR2A and gastric cancer.